Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis

Michelle A. Hurchla; Katherine N. Weilbaecher

doi:10.4161/onci.21060

Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis

Michelle A. Hurchla
, Katherine N. Weilbaecher

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Abstract

Paracrine Hedgehog (Hh) signaling, in which tumor-derived Hh ligands activate stromal cells, has been implicated in the development and progression of many cancers. Recent data suggest that Hh-targeted therapeutics exert direct effects on host cells, thus interrupting a "vicious cycle" to bone metastasis that involves osteoblasts, osteoclasts, and tumor cells.

Original language	English
Pages (from-to)	1411-1413
Number of pages	3
Journal	OncoImmunology
Volume	1
Issue number	8
DOIs	https://doi.org/10.4161/onci.21060
State	Published - 2012

Keywords

Bone metastasis
Hedgehog
Osteoclast
SMO antagonist
Sonic hedgehog
Tumor microenvironment

Access to Document

10.4161/onci.21060

Cite this

@article{81e10434bcb946c8b1f8d1e8e9d6a01f,

title = "Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis",

abstract = "Paracrine Hedgehog (Hh) signaling, in which tumor-derived Hh ligands activate stromal cells, has been implicated in the development and progression of many cancers. Recent data suggest that Hh-targeted therapeutics exert direct effects on host cells, thus interrupting a {"}vicious cycle{"} to bone metastasis that involves osteoblasts, osteoclasts, and tumor cells.",

keywords = "Bone metastasis, Hedgehog, Osteoclast, SMO antagonist, Sonic hedgehog, Tumor microenvironment",

author = "Hurchla, \{Michelle A.\} and Weilbaecher, \{Katherine N.\}",

year = "2012",

doi = "10.4161/onci.21060",

language = "English",

volume = "1",

pages = "1411--1413",

journal = "OncoImmunology",

issn = "2162-4011",

number = "8",

}

TY - JOUR

T1 - Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis

AU - Hurchla, Michelle A.

AU - Weilbaecher, Katherine N.

PY - 2012

Y1 - 2012

N2 - Paracrine Hedgehog (Hh) signaling, in which tumor-derived Hh ligands activate stromal cells, has been implicated in the development and progression of many cancers. Recent data suggest that Hh-targeted therapeutics exert direct effects on host cells, thus interrupting a "vicious cycle" to bone metastasis that involves osteoblasts, osteoclasts, and tumor cells.

AB - Paracrine Hedgehog (Hh) signaling, in which tumor-derived Hh ligands activate stromal cells, has been implicated in the development and progression of many cancers. Recent data suggest that Hh-targeted therapeutics exert direct effects on host cells, thus interrupting a "vicious cycle" to bone metastasis that involves osteoblasts, osteoclasts, and tumor cells.

KW - Bone metastasis

KW - Hedgehog

KW - Osteoclast

KW - SMO antagonist

KW - Sonic hedgehog

KW - Tumor microenvironment

UR - https://www.scopus.com/pages/publications/84886944921

U2 - 10.4161/onci.21060

DO - 10.4161/onci.21060

M3 - Comment/debate

C2 - 23243611

AN - SCOPUS:84886944921

SN - 2162-4011

VL - 1

SP - 1411

EP - 1413

JO - OncoImmunology

JF - OncoImmunology

IS - 8

ER -

Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this